two new biotech drugs for colorectal cancer

You'll see two new biotech drugs for colorectal cancer, Avastin and Erbitux.

Avastin (bevacizumab) is the first angiogenesis inhibitor approved by the FDA. It works by slowing the growth of new blood vessels that tumors need to grow.

It's approved for metastatic colorectal combination with traditional chemotherapy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote